Issue 4/1999
Content (10 Articles)
A Sensitive Docetaxel Assay in Plasma by Solid-Phase Extraction and High Performance Liquid Chromatography – UV Detection: Validation and Suitability in Phase I Clinical Trial Pharmacokinetics
Claude Joseph Ardiet, Brigitte Tranchand, Sylvie Zanetta, Aline Guillot, Elisabeth Bernard, Martine Peguy, Paul Rebattu, Jean-Pierre Droz
Activation-Induced Apoptosis of Peripheral Lymphocytes Treated with 7-Hydroxystaurosporine, UCN-01
Hisao Fukumoto, Tomohide Tamura, Yoshikazu Kamiya, Jitsuo Usuda, Toshihiro Suzuki, Fumihiko Kanzawa, Hyo-Jeong Kuh, Yuichiro Ohe, Nagahiro Saijo, Kazuto Nishio
Geldanamycin as a Potential Anti-Cancer Agent: Its Molecular Target and Biochemical Activity
Len Neckers, Theodor W. Schulte, Edward Mimnaugh
Matrix Metalloproteinase Inhibitors: Applications in Oncology
Desmond Yip, Athar Ahmad, Christos S. Karapetis, Carolyn A. Hawkins, Peter G. Harper
Oral Topoisomerase 1 Inhibitors in Adult Patients: Present and Future
Hans A.J. Gelderblom, Maja J.A. de Jonge, Alex Sparreboom, Jaap Verweij
Toward Checkmate: Biology and Breast Cancer Therapy for the New Millennium
Kathy D. Miller, George W. Sledge Jr.
Volume Contents
Volume Contents
Authors Index